DR3/LARD antibody (C-Term)
Quick Overview for DR3/LARD antibody (C-Term) (ABIN791096)
Target
See all DR3/LARD (TNFRSF25) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- C-Term
-
Purification
- Affinity purified
-
Immunogen
-
A peptide from the C terminal residues of human TNFRSF12 protein
Type of Immunogen: Synthetic peptide -
Isotype
- IgG
-
-
-
-
Application Notes
- Approved: ELISA (1:1000 - 1:10000), IHC (1:50 - 1:200)
-
Comment
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- PBS, pH 7.4, 0.02 % sodium azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20°C for up to 1 year.
-
Expiry Date
- 12 months
-
-
- DR3/LARD (TNFRSF25) (Tumor Necrosis Factor Receptor Superfamily, Member 25 (TNFRSF25))
-
Alternative Name
- TNFRSF25 / DR3
-
Background
-
Name/Gene ID: TNFRSF25
Family: TNF Receptor
Synonyms: TNFRSF25, APO-3, APO3, DDR3, Death receptor 3, DR3, Death receptor beta, LARD, Protein WSL, TR3, WSL, WSL-1, WSL-LR, Apoptosis inducing receptor, TNFRSF12, WSL1, Protein WSL-1, TRAMP -
Gene ID
- 8718
-
UniProt
- Q93038
-
Pathways
- Apoptosis
Target
-